The US' National Cancer Institute (NCI) is doing research into RASopathies, to learn more about the development of tumors in patients with a RASopathy. RASopathies are a group of conditions caused by changes in genes that send signals across the Ras/mitogen-activated protein kinase (Ras/MAPK) pathway.